Lyell Immunopharma Balance Sheet (2019-2025) | LYEL

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Dec2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Assets
Current Assets
Cash & Equivalents 96.67M246.42M134.88M140.41M244.37M564.44M393.50M293.83M222.60M205.74M116.31M123.55M109.43M224.37M286.21M145.65M125.65M133.42M100.30M105.60M120.33M98.80M123.58M
Prepaid Assets 4.93M10.32M12.23M11.49M11.79M11.21M11.61M11.14M11.63M10.66M11.42M8.46M7.87M8.71M9.50M9.07M8.00M5.42M8.58M
Current Assets 617.55M834.84M631.15M626.29M625.71M666.78M659.75M651.29M624.40M606.41M586.85M554.69M534.16M499.82M450.05M379.59M309.18M282.21M328.20M
Non-Current Assets
Property, Plant & Equipment (Net) 77.05M109.64M115.86M120.10M125.71M127.56M125.73M123.02M118.60M113.68M108.10M102.65M97.84M93.10M88.05M48.20M44.20M39.12M36.72M
Long-Term Investments 83.45M150.26M317.51M283.53M224.12M131.44M102.52M70.12M10.00M36.95M32.00M32.00M19.00M19.00M20.11M19.00M28.95M20.06M19.00M
Other Non-Current Assets 1.80M0.47M0.47M0.47M0.47M0.47M0.47M0.47M0.28M0.28M0.28M0.28M0.28M0.28M0.28M4.24M0.29M0.29M0.29M4.62M3.22M2.53M2.54M
Non-Current Assets 290.73M395.03M567.19M501.12M446.40M354.90M317.52M286.27M256.05M228.94M208.13M195.34M160.06M154.32M169.17M111.27M120.62M103.24M79.76M
Assets 908.28M1,229.87M1,198.33M1,127.41M1,072.10M1,021.67M977.27M937.56M880.45M835.35M794.99M750.03M694.22M654.14M619.22M490.86M429.80M385.45M407.96M
Liabilities
Current Liabilities
Accounts Payables 9.40M4.86M3.53M3.21M6.51M4.25M4.79M3.92M5.73M5.80M4.37M4.82M4.89M4.20M3.60M5.37M3.73M3.38M2.57M
Payables 9.40M4.86M3.53M3.21M6.51M4.25M4.79M3.92M5.73M5.80M4.37M4.82M4.89M4.20M3.60M5.37M3.73M3.38M2.57M
Accumulated Expenses 28.02M25.57M25.06M29.06M22.69M21.40M23.57M28.75M22.42M24.83M29.65M28.13M24.91M25.67M29.01M40.82M31.17M28.00M29.31M
Current Deferred Revenue 45.00M6.09M8.23M5.58M4.99M6.22M15.43M11.19M
Total Current Liabilities 49.28M63.66M59.28M46.74M41.05M50.29M51.22M37.03M30.80M34.39M35.06M34.52M32.35M30.88M33.51M53.79M41.28M36.90M31.88M
Non-Current Liabilities
Non-Current Deffered Revenue 89.07M81.88M81.88M79.67M77.87M32.93M37.16M
Preferred Stock Liabilities 519.16M1,010.97M1,010.97M1,010.97M
Operating Leases 50.96M61.50M65.68M66.65M68.81M67.55M67.47M63.17M66.64M66.07M64.64M56.89M61.83M60.22M58.58M50.99M57.09M55.11M53.07M
Other Non-Current Liabilities 0.53M0.90M5.01M4.57M4.45M4.34M4.23M4.11M4.00M3.89M3.78M3.66M3.55M3.44M3.56M3.25M3.14M3.03M2.68M
Total Non-Current Liabilities 189.31M207.01M206.85M193.05M186.40M149.29M153.02M100.20M92.62M94.61M93.64M91.41M87.51M84.20M84.95M104.78M90.14M83.50M76.16M
Total Liabilities 189.84M207.91M211.86M197.62M190.85M153.63M157.24M104.31M96.62M98.50M97.42M95.08M91.06M87.64M88.52M108.03M93.28M86.53M78.84M
Shareholder's Equity
Common Equity -111.11M-240.11M-266.64M-292.53M-334.05M1,021.96M986.47M929.79M881.25M868.04M820.03M833.25M783.83M736.86M697.57M654.95M603.16M566.50M530.70M382.82M336.52M298.92M329.12M
Shareholder's Equity -111.11M-240.11M-266.64M-292.53M-334.05M1,021.96M986.47M929.79M881.25M868.04M820.03M833.25M783.83M736.86M697.57M654.95M603.16M566.50M530.70M382.82M336.52M298.92M329.12M
Liabilities and Shareholders Equity 908.28M1,229.87M1,198.33M1,127.41M1,072.10M1,021.67M977.27M937.56M880.45M835.35M794.99M750.03M694.22M654.14M619.22M490.86M429.80M385.45M407.96M
Retained Earnings -334.14M-451.78M-500.66M-584.36M-652.51M-688.83M-759.08M-767.48M-834.44M-898.33M-949.18M-1002.11M-1062.78M-1108.59M-1153.17M-1345.11M-1397.30M-1439.98M-1478.83M
Treasury Shares -2.03M2.03M2.03M4.55M3.58M2.60M1.63M1.25M0.99M0.87M2.61M2.62M2.78M2.07M5.33M5.17M4.43M0.28M9.11M0.38M0.32M
Shares Outstanding 11.18M15.57M238.55M239.79M242.74M